Experimental Pharmacology
&
Analytical Biochemistry
This unit supplies biochemical and cell-based screenings aimed to assess the biological activity and toxicity profile of small molecules and/or biologics.
The custom cell-based assays and the high-throughput screening (HTS) platforms allow to rapidly characterize the test compound in terms of mechanism of action, cytotoxicity and other properties.
Experimental Activities
Cell culture (maintenance and storage, tests for pathogens and toxins identifications) |
|
|
Isolation of new primary cell lines |
||
Cytotoxicity and proliferation assays |
||
XC50 testing and confirmations |
||
Signal transduction assays |
||
Reporter gene assays |
||
Cytokine release assays |
||
FACS |
||
Chemotaxis, migration and angiogenesis |
||
Live Cell Imaging (Operetta High-Content Imaging System) |
||
Evaluation of ligand-receptor affinity by SPR (Biacore T200) |
||
Immunoassays (ELISA, Western blot, Immunofluorescence) |
||
On the basis of the experimental requirements it is possible to choose between more than 100 cellular models, including: |
||
stabilized cell lines |
|
|
primary cells from different tumour types |
||
unique pre-clinical models of malignant mesothelioma |
||
engineered cell lines expressing GFP or Luciferase reporter genes
|
||